Robert F. Kennedy Jr., President Donald Trump's pick to lead the top U.S. health agency, told U.S. senators during his ...

The COVID-19 pandemic forced investigators conducting clinical trials to use decentralized elements, such as telehealth, to ...

Cancer clinical trials lack diversity, with white patients overrepresented and minorities, women, and the elderly ...

From reduced investment, to a lack of public trust in the industry, it has been difficult, especially for small and ...

Data from the largest patient-reported real-world data exploration underlines new opportunities for medical research to ...

Two top clinicians have been disciplined amid growing concern that Kaiser’s system for monitoring research safety and ethics ...

Dr. Mrinal M Gounder emphasizes the complexity of breast cancer and the necessity for unique treatments for its many variants ...

A novel approach developed by scientists, including Rice University chemist James Tour, could transform treatment for ...

The website changes raise concerns about “the interference of politics with the study and the practice” of science and ...

The U.S. Food and Drug Administration has pulled draft guidance from its website requiring companies to test medicines and ...

A mother and son created an app to match stroke patients with clinical trials, already in use at nearly 30 institutions, ...

A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the ...